1. Home
  2. BYND vs ANL Comparison

BYND vs ANL Comparison

Compare BYND & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beyond Meat Inc.

BYND

Beyond Meat Inc.

HOLD

Current Price

$0.79

Market Cap

346.2M

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

SELL

Current Price

$9.00

Market Cap

350.9M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
BYND
ANL
Founded
2009
2004
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Packaged Foods
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
346.2M
350.9M
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
BYND
ANL
Price
$0.79
$9.00
Analyst Decision
Sell
Strong Buy
Analyst Count
7
1
Target Price
$1.70
$16.00
AVG Volume (30 Days)
30.2M
244.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
53.80
N/A
EPS
N/A
N/A
Revenue
$326,452,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.88
52 Week High
$7.69
$12.09

Technical Indicators

Market Signals
Indicator
BYND
ANL
Relative Strength Index (RSI) 48.49 55.86
Support Level $0.67 $1.37
Resistance Level $0.82 $10.15
Average True Range (ATR) 0.08 0.93
MACD 0.01 -0.37
Stochastic Oscillator 28.25 55.10

Price Performance

Historical Comparison
BYND
ANL

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: